Received: from VI1PR04CA0084.eurprd04.prod.outlook.com (2603:10a6:803:64::19) by GV2PR02MB8917.eurprd02.prod.outlook.com (2603:10a6:150:bd::12) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.569.12; Mon, 2 Nov 2026 12:56:30 +0000 Received: from ZR1PEPF0000E6BB.eurprd07.prod.outlook.com (2603:10a6:803:64:cafe::ad) by VI1PR04CA0084.outlook.office365.com (2603:10a6:803:64::19) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.569.12 via Frontend Transport; Mon, 2 Nov 2026 12:56:30 +0000 Received: from westeu11-emailsignatures-cloud.codetwo.com (20.93.157.195) by ZR1PEPF0000E6BB.mail.protection.outlook.com (10.167.241.74) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.592.5 via Frontend Transport; Mon, 2 Nov 2026 12:56:29 +0000 Received: from GV2PR02MB8917.eurprd02.prod.outlook.com (2603:10a6:150:bd::12) by WA4PR02MB559616.eurprd02.prod.outlook.com with HTTPS; Mon, 2 Nov 2026 12:56:41 +0000 Received: from MMZPR02MB760474.eurprd02.prod.outlook.com ([fe80::f9a5:5a3f:8e81:66cf]) by MMZPR02MB760474.eurprd02.prod.outlook.com ([fe80::f9a5:5a3f:8e81:66cf%3]) with mapi id 15.21.0569.011; Mon, 2 Nov 2026 12:56:27 +0000 Received: from MMZPR02MB760474.eurprd02.prod.outlook.com (2603:10a6:190:31::16) by DB9PR02MB12248.eurprd02.prod.outlook.com (2603:10a6:10:614::8) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.569.12; Mon, 2 Nov 2026 12:56:27 +0000 Received: from AM0PR07CU002.outbound.protection.outlook.com (40.93.65.65) by westeu11-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Mon, 02 Nov 2026 12:56:28 +0000 From: "Kristi Sarap - RA" To: =?Windows-1252?Q?K=E4rolin_Jenas_-_RA?= References: In-Reply-To: Subject: =?Windows-1252?Q?Ed:_K=FCsimus_Meditsiiniuudistelt:_ravimite_tarneh=E4ire?= =?Windows-1252?Q?d_sel_aastal_?= Date: Mon, 2 Nov 2026 14:56:27 +0200 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_06A4_01DD7054.9976B3C0" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQGDhefzuAhfaNmSB+zwi+gECSOovgHFXFzd Authentication-Results: mx.microsoft.com 1; spf=pass (sender IP is 20.93.157.195) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=pass action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 02 Nov 2026 12:56:29.3509 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 26dba20a-1323-4beb-8a50-08df38e0b660 X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: MMZPR02MB760474:EE_|DB9PR02MB12248:EE_|ZR1PEPF0000E6BB:EE_|GV2PR02MB8917:EE_|WA4PR02MB559616:EE_ X-MS-Exchange-Organization-AuthSource: MMZPR02MB760474.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: 26dba20a-1323-4beb-8a50-08df38e0b660 X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|366016|82310400026|23010399003|35042699022|39142699007|31052699007|10067099003|55112099003|22082099003|18002099003|8096899003|56012099006|11063799006|261026121527099003|261022105027099003|261022113327099003|261026140227099003|261009223027099003|261028144727099003|41050700001; X-Forefront-Antispam-Report: CIP:20.93.157.195;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu11-emailsignatures-cloud.codetwo.com;PTR:westeu11-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(366016)(82310400026)(23010399003)(35042699022)(39142699007)(31052699007)(10067099003)(55112099003)(22082099003)(18002099003)(8096899003)(56012099006)(11063799006)(261026121527099003)(261022105027099003)(261022113327099003)(261026140227099003)(261009223027099003)(261028144727099003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 02 Nov 2026 12:56:29.2777 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 26dba20a-1323-4beb-8a50-08df38e0b660 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: MMZPR02MB760474.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-Transport-CrossTenantHeadersStamped: DB9PR02MB12248 X-MS-Exchange-Transport-CrossTenantHeadersStamped: GV2PR02MB8917 X-MS-Exchange-Transport-EndToEndLatency: 00:00:11.7970933 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0569.002 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009284)(140003); X-Microsoft-Antispam-Message-Info: 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 Content-Language: en-us x-ms-exchange-organization-originalclientipaddress: 45.156.32.33 x-ms-exchange-organization-originalserveripaddress: 10.167.241.74 received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 20.93.157.195 as permitted sender) receiver=protection.outlook.com; client-ip=20.93.157.195; helo=westeu11-emailsignatures-cloud.codetwo.com; pr=C X-OlkEid: 00000000354180B9476080459B05E1BF834B446F070034AD76187591974DBF6C4F76951C873A01000200000000002495DA25D80D98438130990BFAFE78050000000011E70000A5956D26D51C394E93A5D7BDA440CFA5 X-MS-Has-Attach: X-MS-TNEF-Correlator: X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|23010399003|366016|31052699007|39142699007|11063799006|56012099006|261009223027099003|261028144727099003|261022105027099003|261022113327099003|261026140227099003|10067099003|18002099003|55112099003|22082099003|8096899003|41050700001; X-Microsoft-Antispam-Message-Info-Original: plgDYxT3/FRQCOSOvuvhZOX55lKzQqhRlD5/l9GpVR548ZHvlbh8kcpx0laNSrdyAkvhHC4Sjc8CkVj+T8KCyneQsD2KpQr+XRFYTYtIbvNgc67YHKV07Bst2UwrmV/Mg4j5Yfy7vDcS915KT6ehpvjj7kWr53wm7Gnjo/JXWlETgBzMMhhiC+PgfKJtSoQpO5vPLEwmiJJqGWK1w5yAcr4IjkKFu9P8gS8vYMsaSh/dGYgU426TNW/SxEIgWCSdukkkJodwwby2NpiGvRjXBCIREmZg7bIuhO8YOwAvPYZJ7vU6wHwTxiqnFHrMbe2zRTF/xAClIsDekjF47Jb/uBhO7V6ofuL2o58wP0ZoS8A4r91XtUGtvWl2+LP38rKDvD9qEe03e1H580g2m4oa6E5HIV9+ENm+AbuLhPpDsq1uNesA6BagKO3mS4rV7qFyV4G6XZ6tjQ6an93sF4t1Im5AOag2WbluOqWmmx5egT6bNlDk/cxaeSmFg9uMAvYljDwXSw1FXsLAyH1z3+xpZc761NgV3P6djqROduelttR1buBlo6nPUWXl/GHvEssE9zSqX5NR9D4mtgCGWQstqsmW4E/9lX/Rme1K4RLPz+SIMrOg1FmaX6WsS5MfoIxT/j93BkqUceqa4q0SKDcB3uLVoI6Uvk6vDt1F5RaXMh1G2IpcYW2CMTp9Qc8/LUCm X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:MMZPR02MB760474.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(23010399003)(366016)(31052699007)(39142699007)(11063799006)(56012099006)(261009223027099003)(261028144727099003)(261022105027099003)(261022113327099003)(261026140227099003)(10067099003)(18002099003)(55112099003)(22082099003)(8096899003)(41050700001);DIR:INT; X-Exchange-RoutingPolicyChecked: eCZwyqVrHa1+uvbN2e/BemlR1oE3MEofoIaIlU94gXXKo6oefVJeuPUBPZ79NDFNfswOqh0SW3UfiadtlYhSfshf+nml7+67PaeZVnAmwDTh3JvQGs/qt6DbLn4K4/u5UFSDfM4C/yo+5BioHH6XFKoU3y3qxC7039AXy87nhILMMA3a96bp6xFBZH2j213Ubl0S2/SHMwie4pPHqKsQiMN5+RW6Sf2eMEZ9etibLSISnhyHxYZlQ9VBCdlwgiB6nX1eQVspr6ZcgNA6hhmSQ3OH6FhwAQww5/Npo/HyWCGzFYTJay7JiozpSM1UCcG4OTWPHdJQmkpZM4BsFE1Rvg== X-OrganizationHeadersPreserved: DB9PR02MB12248.eurprd02.prod.outlook.com X-CodeTwo-MessageID: d779799c-7175-43dd-9f68-8d82e71c5f9b.20261102125628@westeu11-emailsignatures-cloud.codetwo.com X-CodeTwoProcessed: true X-MS-Exchange-Organization-AuthMechanism: 04 X-CrossPremisesHeadersPromoted: ZR1PEPF0000E6BB.eurprd07.prod.outlook.com X-CrossPremisesHeadersFiltered: ZR1PEPF0000E6BB.eurprd07.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersStripped: ZR1PEPF0000E6BB.eurprd07.prod.outlook.com X-OriginatorOrg: m1wmgpm3xrpm87txzdfw82by7.smtp.codetwo.online X-MS-Office365-Filtering-Correlation-Id-Prvs: 8cc3f2e3-9a4f-4ae6-50cc-08df38e0b550 X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[20.93.157.195];Helo=[westeu11-emailsignatures-cloud.codetwo.com] acceptlanguage: en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-11-02T12:56:26.960Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; authentication-results-original: mx.microsoft.com 1; dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; This is a multipart message in MIME format. ------=_NextPart_000_06A4_01DD7054.9976B3C0 Content-Type: text/plain; charset="Windows-1252" Content-Transfer-Encoding: 8bit Saatja: Kristiina Palk > Saadetud: teisipäev, 27. oktoober 2026 10:05 Adressaat: Kristi Sarap - RA > Teema: Küsimus Meditsiiniuudistelt: ravimite tarnehäired sel aastal Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere! Küsin meie „Üks küsimus“ rubriiki: Ravimite tarnehäired sel aastal. Kas tänavu neid rohkem olnud kui eelmisel aastal, millised trendid silma torkavad (mingid teatud ravimgrupid või ravimifirmad)? Vastata võib üsna lühidalt väikese lõiguga ca 1500 tähemärki tühikutega (see paberlehe jaoks nii). Kui on pikemalt kirjutada, siis pikema versiooni saab juurde lisada, see läheks veebiuudistesse, seal ruumi piiramatult. Palun lisage ka kõneisiku pilt juurde. Palun vastake hiljemalt 4.11.2026. Suur tänu ette! Tervitades Kristiina Palk Meditsiiniuudised ajakirjanik-toimetaja +372 5855 2330 ------=_NextPart_000_06A4_01DD7054.9976B3C0 Content-Type: text/html; charset="Windows-1252" Content-Transfer-Encoding: quoted-printable

 

Saatja: Kristiina Palk <Kristiina.Palk@aripaev.ee&g= t;
Saadetud: teisip=E4ev, 27. oktoober 2026 = 10:05
Adressaat: Kristi Sarap - RA <kristi.sarap@ravimiamet.ee= >
Teema: K=FCsimus Meditsiiniuudistelt: ravimite = tarneh=E4ired sel aastal

 

T=E4helepanu! Tegemist on v=E4lisv=F5rgust saabunud = kirjaga.
Tundmatu saatja korral palume linke ja faile mitte = avada.

Tere!

 

K=FCsin meie =84=DCks k=FCsimus=93 = rubriiki: Ravimite tarneh=E4ired sel aastal. Kas t=E4navu neid rohkem = olnud kui eelmisel aastal, millised trendid silma torkavad (mingid = teatud ravimgrupid v=F5i ravimifirmad)?

Vastata v=F5ib =FCsna l=FChidalt = v=E4ikese l=F5iguga ca 1500 t=E4hem=E4rki t=FChikutega (see paberlehe = jaoks nii). Kui on pikemalt kirjutada, siis pikema versiooni saab juurde = lisada, see l=E4heks veebiuudistesse, seal ruumi piiramatult. Palun = lisage ka k=F5neisiku pilt juurde.

 

Palun vastake hiljemalt =  4.11.2026.

 

Suur = t=E4nu ette!

 

Tervitades

Kristiina = Palk

Meditsiiniuudised

ajakirjanik-toimetaj= a

+372 5855 = 2330 

<= /html> ------=_NextPart_000_06A4_01DD7054.9976B3C0--